December 3, 2020
There’s a reason they are called Unicorns
After raising another $65 million Vitra has become the latest digital diabetes company to achieve a $1 billion valuation. This milestone reaching a valuation of $1 billion is commonly known as becoming a Unicorn. This additional $65 million brings the total raised by the company to over $230 million. Frankly we aren’t shocked as digital health continues to be the hottest area for funding. The reality here is this as long as Covid dominates the headlines digital health will remain hot.
What makes Vitra different than Livongo, who was valued at a whopping $18.5 by Teladoc, is their . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
